about
Rome Consensus Conference - statement; human papilloma virus diseases in malesPollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndromeInterleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection.Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments--could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study.Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study.Pathophysiology of reno-ureteral colic.Loss of heterozygosis on chromosome 18q21-23 and muscle-invasive bladder cancer natural history.Epidemiology and risk factors in urolithiasis.Infected congenital urethral diverticulum manifested as a scrotal mass in an adult male: case report and review of the literature.Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: results from a cross-sectional study.Effect of human papillomavirus and Chlamydia trachomatis co-infection on sperm quality in young heterosexual men with chronic prostatitis-related symptoms.Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent.Genital Chlamydia trachomatis infection is related to poor sexual quality of life in young sexually active women.Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study.Chlamydia trachomatis infection is related to poor semen quality in young prostatitis patients.Penile prosthesis surgery in out-patient setting: Effectiveness and costs in the "spending review" era.The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.Finafloxacin for the treatment of urinary tract infections.Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study.Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection.Antibiotic stewardship: a call for action by the urologic community.Microwave-induced thermoablation with Amica-probe is a safe and reproducible method to treat solid renal masses: results from a phase I study.Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries.Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study.Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship.Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio.Fluorodeoxyglucose positron emission tomography may aid the diagnosis of aggressive primary prostate cancer: A case series study.Human papillomavirus infection is not related with prostatitis-related symptoms: results from a case-control study.Transperineal microwave thermoablation in patients with obstructive benign prostatic hyperplasia: a phase I clinical study with a new mini-choked microwave applicator.Re: Park et al.: The Presence of Chlamydia Is Associated With Increased Leukocyte Counts and Pain Severity in Men With Chronic Pelvic Pain Syndrome (Urology 2015;85:574-579).Re: Eggert-Kruse et al.: Are chlamydial lipopolysaccharide-directed antibodies in seminal plasma or serum clinically significant during investigation of male infertility? (Urology 2011;77:1101-1106).Re: May Chlamydia trachomatis be an aetiological agent of chronic prostatitis infection?. Chronic prostatitis due to Chlamydia trachomatis infection: a challenge for the urologist.Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index.Comment on: A potential role for daptomycin in enterococcal infections: what is the evidence?The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study.Nephrogenic adenoma of bladder after ibuprofen abuse.Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study.Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a "Waterloo".Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study.
P50
Q21257274-61772F39-4583-477D-B3BD-AA6C672A19E2Q34119587-A1A5AE9F-9668-434F-867D-BAC1DDB59BE6Q34581890-F2082547-D2F2-4A26-99AA-9FDAAEF3739FQ34589928-2C1E8B6D-F3B3-493F-BB01-9768423061D6Q34701182-C3039401-C96F-43B1-8B34-130AEDDC7857Q35767426-6CA574B3-44F1-42E6-A94F-1CA83EB286C5Q36085868-4916424D-ABEC-43A1-9F70-7BA40F7751AFQ36921830-40F22702-CFF4-4A10-A8BE-D2AF7D5F1435Q37256298-F919825A-EA0A-4A4F-8729-C28F784EE9EEQ37843481-069ADC60-E9EC-4F96-A5EA-150026923876Q37846125-C6584A98-A9E1-4819-A36F-D775DB8619E3Q37850081-119022FF-40E6-4E09-B160-EB1263B6EB52Q37851498-74F81238-4F5A-4063-B51E-805A9FDF568DQ37853262-223ED93F-2CC5-487F-B1F5-D134EC9BD43CQ37854916-7D2EDAD2-9236-44CE-9899-44F56DD22BB7Q38259489-4C9EA1F8-2C91-4637-956B-A997B6FF12DAQ38259866-F45BEE62-AEC3-414C-9204-EC7827E40621Q38526001-0D898D7B-6171-4AFB-BF51-0C833F2DF09FQ39200312-4003BB73-C562-4C23-AAC7-604550A81134Q39211390-86059D8B-CF8F-4B9E-AE80-9157AEE85ED8Q39405714-849C30C0-8EB6-46EF-BFF7-CB125E09ABA9Q39568761-62BBC4C9-AB8E-4BC2-9067-BD29077F9278Q39834891-C01FB7F3-9A5F-4979-BEEB-69439A834C64Q40496147-25DF1E39-C10F-4CDE-AF20-2D14934421C6Q40910767-F73566C5-7655-47A8-8D6B-0E00DC51D9D5Q41702226-134128F5-7D04-44E7-B967-B6ED3F27F42FQ41852965-928554DD-A8E9-4710-9D03-A3409786DDBAQ42216972-3142D156-79B2-4F15-96D4-824684ED4E86Q43362469-766C5846-A8A6-4D85-B22B-026878E8FB64Q43407766-FBE6AAF9-7147-4ED8-81C6-B0203BBBDD09Q43411891-81F7668B-E681-471C-99CD-D5FE96078938Q43412621-6FA98CEE-3B65-4372-9CCC-788AD69427EDQ43423241-824C107F-FDB6-4210-AFF5-C021F713599BQ44106297-F6E443F5-5211-4560-BB43-2F0B86230AD4Q44145786-3A08B30E-AFB9-482A-AB93-CDD0051962A4Q44464728-C2C20EF2-8ACD-49F2-9E78-850312B038ADQ44571041-AE099EAA-1475-4445-A22E-4E17BCA830B8Q44843447-C36458D0-ADD5-4BB0-8B74-19D3FF6E8DF5Q44844480-54F7F6A7-F313-4573-8A00-ACA22135BA13Q44887089-CEA07CB7-B88A-46A5-BC76-E3FA4AF7EF90
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Riccardo Bartoletti
@ast
Riccardo Bartoletti
@en
Riccardo Bartoletti
@es
Riccardo Bartoletti
@nl
Riccardo Bartoletti
@sl
type
label
Riccardo Bartoletti
@ast
Riccardo Bartoletti
@en
Riccardo Bartoletti
@es
Riccardo Bartoletti
@nl
Riccardo Bartoletti
@sl
prefLabel
Riccardo Bartoletti
@ast
Riccardo Bartoletti
@en
Riccardo Bartoletti
@es
Riccardo Bartoletti
@nl
Riccardo Bartoletti
@sl
P1053
I-1291-2017
P106
P1153
7004613636
P21
P214
8155564065613002561
P31
P3829
P496
0000-0002-0021-0302
P735
P7859
viaf-8155564065613002561